Sponsor:
DualityBio Inc.
Code:
NCT05150691
Conditions
HER2-positive Advanced Solid Tumor
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
DB-1303/BNT323
Pertuzumab Injection
Ritonavir
Itraconazole
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations